Thrombophilia and maternal mortality: risk factors and preventive approaches

References

• White RH. The epidemiology of venous thromboembolism. Circulation107(90231), 4–8 (2003).
   PubMed Web of Science ®Google Scholar
• Walker AL; Ministry of Health. Report on Confidential Enquiries into Maternal Deaths in England and Wales, 1952–1954. Her Majesty’s Stationery Office, London, UK (1957).
   Google Scholar
• Hibbard BM; Department of Health. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991–1993. Her Majesty’s Stationery Office, London, UK (1996).
   Google Scholar
• Lewis G, Drife JO; National Institute for Clinical Excellence. Why Mothers Die 1997–1999: the Fifth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. Royal College of Obstetricians and Gynaecologists Press, London, UK (2001).
   Google Scholar
• Lewis GM, Drife JO; Royal College of Obstetricians and Gynaecologists. Why Mothers Die: Confidential Enquiry into Maternal and Child Health: the Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom: Midwifery Summary and Key Findings. Royal College of Obstetricians and Gynaecologists Press, London, UK (2004).
   Google Scholar
• Atrash HK, Koonin LM, Lawson HW, Franks AL, Smith JC. Maternal mortality in the United States, 1979–1986. Obstet. Gynecol.76(6), 1055–1060 (1990).
   PubMed Web of Science ®Google Scholar
• Franks AL, Atrash HK, Lawson HW, Colberg KS. Obstetrical pulmonary embolism mortality, United States, 1970–85. Am. J. Public Health80(6), 720–722 (1990).
   PubMedGoogle Scholar
• Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987–1990. Obstet. Gynecol.88(2), 161–167 (1996).
   PubMed Web of Science ®Google Scholar
• Chang J, Elam-Evans LD, Berg CJ et al. Pregnancy-related mortality surveillance – United States, 1991–1999. MMWR Surveill. Summ.52(2), 1–8 (2003).
   PubMedGoogle Scholar
• Panting-Kemp A, Geller SE, Nguyen T et al. Maternal deaths in an urban perinatal network, 1992–1998. Am. J. Obstet. Gynecol.183(5), 1207–1212 (2000).
   PubMedGoogle Scholar
• Friend JR, Kakkar VV. The diagnosis of deep vein thrombosis in the puerperium. J. Obstet. Gynaecol. Br. Commonw.77(9), 820–823 (1970).
   PubMedGoogle Scholar
• Macklon NS, Barry J, Greer IA. Duplex ultrasound screening for deep venous thrombosis in the puerperium. Br. J. Obstet. Gynaecol.102(3), 255–256 (1995).
   PubMedGoogle Scholar
• Anderson FA Jr, Wheeler HB, Goldberg RJ et al. A population-based perspective of the hospital incidence and case–fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch. Intern. Med.151(5), 933–938 (1991).
   PubMed Web of Science ®Google Scholar
• Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J. Intern. Med.232(2), 155–160 (1992).
   PubMed Web of Science ®Google Scholar
• Samuelsson E, Hagg S. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users. Acta Obstet. Gynecol. Scand.83(7), 674–681 (2004).
   PubMed Web of Science ®Google Scholar
• Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott. Med. J.41(3), 83–86 (1996).
   PubMed Web of Science ®Google Scholar
• Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet. Gynecol.94(4), 595–599 (1999).
   PubMed Web of Science ®Google Scholar
• Andersen BS, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium – an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet. Gynecol. Scand.77(2), 170–173 (1998).
   PubMed Web of Science ®Google Scholar
• McColl MD, Ramsay JE, Tait RC et al. Risk factors for pregnancy associated venous thromboembolism. Thromb. Haemost.78(4), 1183–1188 (1997).
   PubMed Web of Science ®Google Scholar
• Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. Br. J. Obstet. Gynaecol.108(1), 56–60 (2001).
   Google Scholar
• Gherman RB, Goodwin TM, Leung B et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet. Gynecol.94(5 Pt 1), 730–734 (1999).
   PubMed Web of Science ®Google Scholar
• Huisman MV, Buller HR, ten Cate JW et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest95(3), 498–502 (1989).
   PubMed Web of Science ®Google Scholar
• Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet. Gynecol. Surv.54(4), 265–271 (1999).
   PubMedGoogle Scholar
• Cogo A, Lensing AW, Prandoni P, Hirsh J. Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch. Intern. Med.153(24), 2777–2780 (1993).
   PubMed Web of Science ®Google Scholar
• Kearon C. Natural history of venous thromboembolism. Circulation107(23 Suppl. 1), I22–I30 (2003).
   PubMed Web of Science ®Google Scholar
• Polak JF, Wilkinson DL. Ultrasonographic diagnosis of symptomatic deep venous thrombosis in pregnancy. Am. J. Obstet. Gynecol.165(3), 625–629 (1991).
   PubMed Web of Science ®Google Scholar
• Bergqvist A, Bergqvist D, Hallbook T. Deep vein thrombosis during pregnancy. A prospective study. Acta Obstet. Gynecol. Scand.62(5), 443–448 (1983).
   PubMed Web of Science ®Google Scholar
• Ouriel K, Green RM, Greenberg RK, Clair DG. The anatomy of deep venous thrombosis of the lower extremity. J. Vasc. Surg.31(5), 895–900 (2000).
   PubMed Web of Science ®Google Scholar
• May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology8(5), 419–427 (1957).
   PubMedGoogle Scholar
• Ginsberg JS, Brill-Edwards P, Burrows RF et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb. Haemost.67(5), 519–520 (1992).
   PubMed Web of Science ®Google Scholar
• Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br. J. Obstet. Gynaecol.104(2), 191–197 (1997).
   PubMedGoogle Scholar
• Macklon NS, Greer IA. The deep venous system in the puerperium: an ultrasound study. Br. J. Obstet. Gynaecol.104(2), 198–200 (1997).
   PubMedGoogle Scholar
• Bergqvist A, Bergqvist D, Hedner U. Oral contraceptives and venous thromboembolism. Br. J. Obstet. Gynaecol.89(5), 381–386 (1982).
   PubMedGoogle Scholar
• Nelson SM, Greer IA. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium. Obstet. Gynecol. Clin. North Am.33(3), 413–427 (2006).
   PubMed Web of Science ®Google Scholar
• Walker ID. Congenital thrombophilia. Baillieres Clin. Obstet. Gynaecol.11(3), 431–445 (1997).
   PubMed Web of Science ®Google Scholar
• Zheng H, Tzeng CC, Butt C, Randell E, Xie YG. An extremely low prevalence of factor V Leiden, FIIG20210A and FXIIIV34L in Taiwan Chinese population. Thromb. Haemost.87(6), 1081–1082 (2002).
   PubMedGoogle Scholar
• Zoller B, Hillarp A, Berntorp E, Dahlback B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annu. Rev. Med.48, 45–58 (1997).
   PubMed Web of Science ®Google Scholar
• Margaglione M, Bossone A, Coalizzo D et al. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile. Thromb. Haemost.87(1), 32–36 (2002).
   PubMedGoogle Scholar
• Clark P, Brennand J, Conkie JA et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb. Haemost.79(6), 1166–1170 (1998).
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood88(10), 3698–3703 (1996).
   PubMed Web of Science ®Google Scholar
• McColl MD, Walker ID, Greer IA. A mutation in the prothrombin gene contributing to venous thrombosis during pregnancy. Br. J. Obstet. Gynaecol.105(8), 923–925 (1998).
   PubMedGoogle Scholar
• McColl MD, Ellison J, Reid F et al. Prothrombin 20210 G–>A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. Br. J. Obstet. Gynaecol.107(4), 565–569 (2000).
   Google Scholar
• Gerhardt A, Scharf RE, Beckmann MW et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N. Engl. J. Med.342(6), 374–380 (2000).
   PubMed Web of Science ®Google Scholar
• Ellison J, Clark P, Walker ID, Greer IA. Effect of supplementation with folic acid throughout pregnancy on plasma homocysteine concentration. Thromb. Res.114(1), 25–27 (2004).
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Romero R, Feinberg RF et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am. J. Obstet. Gynecol.161(2), 369–373 (1989).
   PubMed Web of Science ®Google Scholar
• Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N. Engl. J. Med.346(10), 752–763 (2002).
   PubMed Web of Science ®Google Scholar
• Nelson SM, Greer IA. Artificial reproductive technology and the risk of venous thromboembolic disease. J. Thromb. Haemost.4(8), 1661–1663 (2006).
   PubMed Web of Science ®Google Scholar
• Pabinger I, Grafenhofer H, Kaider A et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J. Thromb. Haemost.3(5), 949–954 (2005).
   PubMed Web of Science ®Google Scholar
• De Stefano V, Martinelli I, Rossi E et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br. J. Haematol.135(3), 386–391 (2006).
   PubMed Web of Science ®Google Scholar
• Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb. Haemost.63(2), 319–320 (1990).
   PubMed Web of Science ®Google Scholar
• Robertson L, Wu O, Langhorne P et al. Thrombophilia in pregnancy: a systematic review. Br. J. Haematol.132(2), 171–196 (2006).
   PubMed Web of Science ®Google Scholar
• Gerhardt A, Scharf RE, Zotz RB. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb. Haemost.90(1), 77–85 (2003).
   PubMed Web of Science ®Google Scholar
• Langlois NJ, Wells PS. Risk of venous thromboembolism in relatives of symptomatic probands with thrombophilia: a systematic review. Thromb. Haemost.90(1), 17–26 (2003).
   PubMedGoogle Scholar
• Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet353(9160), 1258–1265 (1999).
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(3 Suppl.), 627S–644S (2004).
   PubMed Web of Science ®Google Scholar
• Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br. Med. J.314(7076), 253–257 (1997).
   PubMed Web of Science ®Google Scholar
• Clark P, Twaddle S, Walker ID, Scott L, Greer IA. Cost–effectiveness of screening for the factor V Leiden mutation in pregnant women. Lancet359(9321), 1919–1920 (2002).
   PubMedGoogle Scholar
• Wu O, Robertson L, Twaddle S et al. Screening for thrombophilia in high-risk situations: a meta-analysis and cost–effectiveness analysis. Br. J. Haematol.131(1), 80–90 (2005).
   PubMed Web of Science ®Google Scholar
• Darvall KAL, Sam RC, Silverman SH, Bradbury AW, Adam DJ. Obesity and Thrombosis. Eur. J. Vasc. Endovasc. Surg. (2007) (In Press).
   Google Scholar
• Kakkos SK, Daskalopoulou SS, Daskalopoulos ME, Nicolaides AN, Geroulakos G. Review on the value of graduated elastic compression stockings after deep vein thrombosis. Thromb. Haemost.96(4), 441–445 (2006).
   PubMed Web of Science ®Google Scholar
• Bates SM, Ginsberg JS. Anticoagulants in pregnancy: fetal effects. Baillieres Clin. Obstet. Gynaecol.11(3), 479–488 (1997).
   PubMedGoogle Scholar
• Wesseling J, Van Driel D, Heymans HS et al. Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb. Haemost.85(4), 609–613 (2001).
   PubMed Web of Science ®Google Scholar
• Flessa HC, Kapstrom AB, Glueck HI, Will JJ. Placental transport of heparin. Am. J. Obstet. Gynecol.93(4), 570–573 (1965).
   PubMed Web of Science ®Google Scholar
• Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb. Res.34(6), 557–560 (1984).
   PubMed Web of Science ®Google Scholar
• Forestier F, Daffos F, Rainaut M, Toulemonde F. Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb. Haemost.57(2), 234 (1987).
   PubMed Web of Science ®Google Scholar
• Nelson-Piercy C. Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Baillieres Clin. Obstet. Gynaecol.11(3), 489–509 (1997).
   PubMed Web of Science ®Google Scholar
• Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood106(2), 401–407 (2005).
   PubMed Web of Science ®Google Scholar
• Brill-Edwards P, Ginsberg JS, Gent M et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N. Engl. J. Med.343(20), 1439–1444 (2000).
   PubMed Web of Science ®Google Scholar
• Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case–control study. Br. Med. J.322(7294), 1089–1093; discussion 1093–1084 (2001).
   PubMed Web of Science ®Google Scholar
• Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am. J. Obstet. Gynecol.162(3), 731–734 (1990).
   PubMed Web of Science ®Google Scholar
• Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(3 Suppl.), 311S–337S (2004).
   PubMedGoogle Scholar
• Kanagalingam MG, Forouhi NG, Greer IA, Sattar N. Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. Br. J. Obstet. Gynaecol.112(10), 1431–1433 (2005).
   Google Scholar
• Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med. J. Aust.184(2), 56–59 (2006).
   PubMed Web of Science ®Google Scholar
• Mayor S. Obesity in children in England continues to rise. Br. Med. J.330(7499), 1044 (2005).
   PubMedGoogle Scholar
• Kucher N, Koo S, Quiroz R et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N. Engl. J. Med.352(10), 969–977 (2005).
   PubMed Web of Science ®Google Scholar
• Taylor GM, McKenzie CA, Mires GJ. Use of a computerised maternity information system to improve clinical effectiveness: thromboprophylaxis at caesarean section. Postgrad. Med. J.76(896), 354–356 (2000).
   PubMed Web of Science ®Google Scholar
• Dargaud Y, Rugeri L, Ninet J, Negrier C, Trzeciak MC. Management of pregnant women with increased risk of venous thrombosis. Int. J. Gynecol. Obstet.90(3), 203–207 (2005).
   PubMed Web of Science ®Google Scholar